VIATRIS INC

Health Issues

H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark

Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022

TargetedSENATE · HOUSE OF REPRESENTATIVES